Injective launched a new route for transferring USD Coin (USDC) through LI.FI and Jumper on October 16, utilizing Circle's Cross-Chain Transfer Protocol (CCTP). This addition offers users an alternative way to move USDC to Injective's network, which has supported native USDC and CCTP transfers since May 7 across more than 20 blockchains. The CCTP process involves burning USDC on the source chain and minting it on the destination chain. Injective's network has processed over three billion transactions cumulatively, with more than 46 million in the last 30 days, highlighting growing activity. Long-term price targets for Injective (INJ) remain optimistic, with projections between $80 and $200.
Injective (INJ) is trading at Rp158.358 on Pluang as of Oct 17, 2026 16:01 WIB, down 2.98% in the last day. The market cap stands at Rp15,79 trillion, with a 24-hour trading volume of Rp3,51 trillion. Pluang users show a buying preference with 64% buy orders and typically hold INJ for 38 days, reflecting steady investor interest amid the network's growing transaction activity.
Injective (INJ) surged 68.6% to $9.03 over 30 days, driven by U.S. regulatory compliance steps and multiple ETF proposals. The company registered its subsidiary as a transfer agent with the SEC, enhancing its U.S. market presence, though no ETF appro...
Injective (INJ) surged 27.43% to $9.269 following announcements that two proposed U.S. ETFs plan to hold and stake the token. The 21Shares Injective ETF may stake part of its holdings if it poses no legal risk, while the Canary Staked INJ ETF intends...
Celestia (TIA) surged 30.32% to $0.696, topping the crypto gainers among the 90 largest cryptocurrencies by market cap. Other notable gainers include Injective (27.40%), LayerZero (22.16%), Ether.fi (16.28%), and NEAR Protocol (15.64%). Meanwhile, Bi...
Injective (INJ) experienced a significant price increase of 25.53% within 24 hours on Binance spot trading, reaching $9.18 and earlier touching $9.36. This surge pushed INJ above its seven-, 20-, 50-, and 200-day simple moving averages as well as its...
Injective (INJ) has surged over 30% following a breakout from a cup-and-handle pattern, with a market analyst projecting a potential price target near $14. This target is above INJ's recent 2026 high of $9.37 reached on October 16. The token's open i...
